
TL;DR
Comparing AXA Health vs Aviva for cancer cover in the UK? WeCovr, with over 900,000 policies of various kinds issued, breaks down their oncology pathways and drug access to help you choose suitable private medical insurance.
Key takeaways
- AXA Health offers a more flexible approach to cancer drugs, often covering those not on Aviva's approved list if recommended by a specialist.
- Aviva's 'Expert Select' hospital network and approved drug list aim to ensure quality and manage costs, but can be more restrictive.
- Both insurers provide comprehensive cancer pathways from diagnosis to aftercare, including dedicated nurse support and mental health services.
- Your choice of underwriting (Moratorium vs. Full Medical) significantly impacts cover for any pre-existing conditions that could be related to cancer.
- A broker like WeCovr can compare the nuanced details of each policy against your specific needs at no extra cost to you.
A cancer diagnosis is one of life’s most daunting challenges. Navigating the journey ahead requires not just medical excellence but also clarity and support. Here at WeCovr, where we've helped arrange over 900,000 policies of various kinds, we know that understanding your private medical insurance (PMI) is a critical part of that support system. In the UK, two of the leading insurers, AXA Health and Aviva, offer robust cancer cover, but their approaches have crucial differences.
This article provides an expert, head-to-head comparison of AXA Health and Aviva's cancer cover. We’ll delve into their oncology pathways, their stances on experimental drugs, and the fine print that could make all the difference, helping you make a more informed choice for your circumstances.
A head-to-head comparison of oncology pathways and experimental drugs
When choosing private health cover, cancer care is often the single most important benefit for our clients. It’s the ultimate ‘what if’ scenario where the value of PMI truly comes to the fore. Both AXA Health and Aviva provide comprehensive cancer cover as a core component of their policies, promising to pay for your eligible cancer treatment in full.
However, the journey from diagnosis to recovery is complex, and the way each insurer manages this pathway differs significantly. The key distinctions lie in their philosophy, their flexibility with new and experimental treatments, and the structure of their hospital networks.
Let's break down how they compare.
Core Cancer Cover: The Central Promise
At its heart, the cancer cover from both AXA and Aviva is designed to fund private treatment for acute cancer that arises after you take out your policy. This is a fundamental principle of UK private medical insurance.
A Critical Note on Pre-existing and Chronic Conditions: Standard UK PMI is designed for acute conditions—illnesses that are curable and short-term. It does not cover chronic conditions (long-term illnesses needing ongoing management, like diabetes) or pre-existing conditions you had before your policy began. If cancer is diagnosed and later requires long-term management, it may be classed as chronic, and cover could be limited. We'll explore this further in the underwriting section.
Both insurers' core cancer benefit typically includes:
- Hospital charges and specialist fees.
- Diagnostic tests, scans (CT, MRI, PET), and consultations.
- Surgery, including reconstructive surgery.
- Chemotherapy and radiotherapy.
- Dedicated cancer care support teams.
The divergence begins when we look at how these services are delivered and the choices available to you.
The Cancer Care Pathway: A Step-by-Step Comparison
Imagine a potential cancer journey. Here’s how it might unfold with each insurer.
| Stage of Journey | AXA Health Approach | Aviva Approach |
|---|---|---|
| 1. Initial Suspicion | GP refers you to a specialist. With an outpatient option, AXA facilitates a prompt private consultation. | GP refers you to a specialist. Aviva's 'Expert Select' pathway guides you to a specialist from their approved network. |
| 2. Diagnosis | Covers costs for consultations, diagnostic tests, and scans to confirm the diagnosis without NHS waiting lists. | Covers diagnostic tests and scans. The choice of diagnostic facility might be guided by the Expert Select network. |
| 3. Treatment Planning | Your specialist, in consultation with you, develops a treatment plan. AXA provides a dedicated cancer nurse for support. | Your specialist devises a treatment plan. Aviva provides access to a dedicated cancer claims team and support from Macmillan. |
| 4. Treatment | Full cover for eligible surgery, radiotherapy, and chemotherapy at a hospital from your chosen list. | Full cover for eligible treatments. These must be delivered within Aviva's 'Expert Select' hospital network. |
| 5. Advanced/Drug Therapy | High flexibility. Covers any licensed cancer drug recommended by your specialist. Also considers unlicensed drugs on a case-by-case basis. | Covers drugs on Aviva's approved list of cancer drugs. This list is extensive but can be more restrictive than AXA's approach. |
| 6. Aftercare & Monitoring | Covers follow-up consultations and monitoring scans. Palliative care is covered if cancer is diagnosed while on the policy. | Covers follow-up care and monitoring. Palliative care and support for incurable cancer are included. |
| 7. Mental Health Support | Provides access to counselling and psychiatric support through their Mind Health service. | Provides mental health support via the Aviva DigiCare+ app and other policy benefits. |
This table shows two distinct philosophies. AXA tends to offer more patient and specialist-led choice, while Aviva provides a more structured, quality-controlled pathway designed to optimise outcomes and manage costs.
Experimental Drugs and Advanced Therapies: The Deciding Factor?
For many, this is the most critical point of comparison. Cancer treatment is evolving at a breathtaking pace, with new biological therapies, immunotherapies, and targeted drugs emerging constantly. Access to these treatments can be life-changing.
AXA Health: The Flexible Approach
AXA Health's cancer pledge is one of the most generous in the UK market regarding drug choice. Their philosophy is to put faith in the treating oncologist.
- Licensed Drugs: AXA will cover any cancer drug that is licensed for use in the UK, provided it is recommended by your specialist for your condition, even if NICE (the National Institute for Health and Care Excellence) has not approved it for NHS use due to cost.
- Unlicensed / Experimental Drugs: This is where AXA often stands out. They may cover the cost of an unlicensed drug if it's used as part of a clinical trial and your specialist provides a clear rationale for its use. This can open doors to cutting-edge treatments that aren't yet widely available. Their commitment is to follow the clinical evidence presented by your consultant.
Insider Tip: AXA's flexibility is a significant advantage for those who want the reassurance that they can access the widest possible range of treatments, should their specialist recommend them.
Aviva: The Curated Approach
Aviva's "Speedy Cancer Care" promise is built on their 'Expert Select' framework. This extends to the drugs they cover.
- Approved Drug List: Aviva maintains a list of approved cancer drugs. This list is comprehensive and includes most standard and many advanced therapies. However, if a drug is not on this list, it will not be covered.
- Rationale: Aviva's reasoning is based on clinical effectiveness and evidence. They work with oncologists to curate a list of treatments with a proven track record. This helps ensure quality and manage the overall cost of care, which in turn helps keep premiums competitive.
- Less Flexibility: The downside is a lack of flexibility. If your specialist recommends a brand-new or experimental drug that is not yet on Aviva's list, you may not be covered for it, even if it's licensed in the UK.
Which is better? There is no single "better" option; it's a trade-off.
- Choose AXA Health if your priority is maximum flexibility and access to the very latest treatments as recommended by your specialist.
- Consider Aviva if you are comfortable with a curated list of proven, effective treatments and hospital networks, which can often translate into a more affordable premium.
Value-Added Services: Support Beyond Treatment
A cancer journey is emotionally and physically taxing. Both insurers recognise this and provide excellent support services that go beyond funding medical bills.
AXA Health's Support Ecosystem
- Dedicated Cancer Nurses: From the moment of diagnosis, you are assigned a dedicated nurse who can explain terminology, coordinate care, and offer emotional support.
- Health at Hand: A 24/7 helpline staffed by nurses, pharmacists, and counsellors for medical advice at any time.
- Mind Health Service: Access to counsellors and psychologists to help you and your family cope with the mental strain of a cancer diagnosis.
- Working Body: Physiotherapy support to help with physical recovery after treatment.
Aviva's Digital and Partner Support
- Aviva DigiCare+ App: This is a standout feature providing a suite of digital health and wellbeing services, including:
- Digital GP appointments
- Mental health consultations
- Nutritional advice
- Second medical opinions
- Macmillan Cancer Support: Aviva has a close working relationship with Macmillan, providing patients with access to their renowned clinical and emotional support resources.
- Expert Select: While a network, Aviva positions it as a value-add, ensuring you are treated in facilities with proven expertise in your specific type of cancer.
An expert broker, such as WeCovr, can help you evaluate which of these bundled services aligns best with your personal and family needs. We can also help you secure discounts on other policies, like life insurance, when you purchase PMI, and give you complimentary access to our AI-powered calorie tracking app, CalorieHero, to support your general wellbeing.
How Underwriting Affects Your Cancer Cover
When you apply for PMI, the insurer will underwrite your policy. This process determines how they will treat any medical conditions you've had in the past. This is crucial for cancer cover.
- Full Medical Underwriting (FMU): You disclose your full medical history upfront. The insurer will explicitly state any exclusions on your policy certificate. For example, if you had treatment for abnormal cells a few years ago, they might place a permanent exclusion on related cancers. This provides certainty from day one.
- Moratorium Underwriting (Mori): You do not declare your medical history. The policy automatically excludes treatment for any condition you've had symptoms, advice, or treatment for in the 5 years before joining. However, if you go 2 full, continuous years on the policy without needing treatment, advice, or having symptoms for that condition, the exclusion may be lifted.
Scenario:
- Client A (FMU): Had a benign lump removed 3 years ago. They declare this. The insurer places an exclusion on "investigation and treatment of breast conditions". They know exactly where they stand.
- Client B (Mori): Had the same procedure but chooses a moratorium policy. For the first two years, any breast-related issue will not be covered. If a new, unrelated cancer (e.g., lung cancer) develops, it would be covered. If they go two full years with no breast issues, cover for new breast conditions may be available.
Understanding this choice is vital. A mistake here can lead to a declined claim. Our advisers at WeCovr specialise in explaining these options to ensure your policy is set up correctly for your history and needs.
Making a Cancer Claim: The Process with AXA and Aviva
If you receive a cancer diagnosis, the last thing you want is a complicated claims process. Both insurers have streamlined this.
Typical Claim Steps:
- See your GP: Your journey starts with your NHS GP, who provides an open referral letter if they suspect cancer.
- Contact your Insurer: You call your insurer's claims line. With AXA, you’ll speak to the cancer care team. With Aviva, you’ll start with their claims team, who will quickly involve the specialist cancer unit.
- Authorisation: The insurer authorises the initial consultation and diagnostics.
- Treatment Pathway: Once a diagnosis is confirmed and a treatment plan is proposed, the insurer authorises the plan. The dedicated support teams (AXA's nurses, Aviva's cancer team) help coordinate the care.
- Direct Billing: The insurer settles the bills directly with the hospital and specialists. You only pay your chosen excess.
Both providers are known for having efficient and compassionate claims processes for cancer. The key is to get pre-authorisation before incurring any costs.
Does private medical insurance cover all types of cancer?
What happens if my cancer becomes chronic?
Can I get cover from AXA or Aviva if I have had cancer before?
Is it better to choose a policy with a guided hospital list like Aviva's Expert Select?
Conclusion: AXA Health or Aviva – Which Is a Better Fit for You?
So, which insurer offers the better cancer cover? The honest answer is: it depends entirely on your priorities.
-
AXA Health is likely a stronger fit if:
- Your primary concern is having the maximum possible flexibility in treatment options.
- You want the reassurance of access to experimental or unlicensed drugs if your specialist recommends them.
- You prefer a wider choice of hospitals and specialists, and are willing to potentially pay a higher premium for it.
-
Aviva is likely a suitable option if:
- You are looking for comprehensive but cost-effective cover.
- You are comfortable with a curated network of hospitals and a defined list of approved drugs, chosen for their proven effectiveness.
- You highly value integrated digital health tools like the Aviva DigiCare+ app.
Both AXA Health and Aviva provide outstanding, market-leading cancer care pathways that can offer immense peace of mind and fast access to life-saving treatment. The differences are nuanced but significant.
Navigating these details can be overwhelming. As an independent, FCA-regulated PMI broker, WeCovr can provide a full market comparison, explain the subtle policy differences in plain English, and help you find a policy that aligns with your budget and, most importantly, your health priorities.
Contact us today for a free, no-obligation quote and a personalised comparison.
Disclaimer: This is general guidance only and does not constitute formal tax or financial advice. Tax treatment depends on individual circumstances, policy terms, and HMRC interpretation, which cannot be guaranteed in advance. Whenever applicable, businesses and individuals should always consult a qualified accountant or tax adviser before arranging such policies.
Sources
- NHS England
- National Institute for Health and Care Excellence (NICE)
- Financial Conduct Authority (FCA)
- Macmillan Cancer Support
- AXA Health & Aviva policy literature (2024/2025)
Start with your Protection Score, then decide whether private health cover is the right fit
Check where health access sits in your overall protection picture before deciding whether to compare private health cover.
Spot whether NHS access risk is the real issue
See if PMI is the gap to fix first
Get health insurance help only if it makes sense for you
Get your score
Start with your protection score
Check your current position first, then get health insurance help if you need it.
Check your current resilience
Score your income, health access and family protection position in a few minutes.
See where private cover helps
Understand whether faster diagnosis and treatment is a priority gap.
Continue to tailored PMI help
If health access is the issue, continue to tailored PMI help.
What you get
A quick view of your current protection position
A clearer idea of where the biggest gaps may be
A direct route to tailored help if you want it








